Becker's ASC Review

March/April Issue of Becker's ASC Review

Issue link: https://beckershealthcare.uberflip.com/i/1230114

Contents of this Issue

Navigation

Page 32 of 63

Learn more by calling 1.781.790.0845 or visit www.echosens.us FibroScan ® Intended Use / Indications for Use: The Family of Products (Models: 502 Touch, 530 Compact, and 430 Mini+) is intended to provide 50Hz shear wave speed measurements and estimates of tissue stiffness as well as 3.5 MHz ultrasound coefficient of attenuation (CAP: Controlled Attenuation Parameter) in internal structures of the body. FibroScan® Family of Products (Models: 502 Touch, 530 Compact, and 430 Mini+) is indicated for noninvasive measurement in the liver of 50 Hz shear wave speed and estimates of stiffness as well as 3.5 MHz ultrasound coefficient of attenuation (CAP: Controlled Attenuation Parameter).The shear wave speed and stiffness, and CAP may be used as an aid to diagnosis and monitoring of adult patients with liver disease, as part of an overall assessment of the liver. Shear wave speed and stiffness may be used as an aid to clinical management of pediatric patients with liver disease. ©Copyright 2020 Echosens North America COST EFFECTIVELY IDENTIFY & MONITOR PATIENTS WITH NAFLD & NASH • Quick and painless examination • Simultaneously quantifies liver stiffness and fat • The reference for major medical association guidelines and validated by 2,500+ peer reviewed publications • Examinations covered by most major insurance providers for diagnosis and monitoring of chronic liver diseases

Articles in this issue

Links on this page

view archives of Becker's ASC Review - March/April Issue of Becker's ASC Review